Not Available
Property Name | Property Value | Unit | Raw Value | Raw Unit | Annotation | Reference |
---|---|---|---|---|---|---|
T Max | 5.0 | h | 2-8 | h | DRUGBANK | |
Metabolic | 15.0 | % | 15 | % | Active metabolite; | DRUGBANK | Metabolic | 33.0 | % | 33 | % | Derivative; | DRUGBANK | Metabolic | 22.0 | % | 22 | % | Components; | DRUGBANK | Metabolic | 4.0 | % | 4 | % | Drug form; | DRUGBANK |
Clearance | 216.0 | L/h | 216.0 | L/h | Total clearance; Multiple dose; | DRUGBANK | Clearance | 281.0 | L/h | 281.0 | L/h | Total clearance; at steady state; | DRUGBANK |
Volume of Distribution | 6433.0 | L | 6433.0 | L | Apparent volume of distribution; | DRUGBANK |
Half-life | 12.0 | h | 7-17 | h | Single dose; | DRUGBANK | Half-life | 14.6 | h | 14.6 | h | elimination half-life; Multiple dose; | DRUGBANK | Half-life | 21.6 | h | 21.6 | h | DRUGBANK | Half-life | 13.8 | h | 13.8 | h | DRUGBANK | Half-life | 10.4 | h | 10.4 | h | DRUGBANK |
Eliminate Route | 97.1 | % | 97.1 | % | Faeces excretion; | DRUGBANK | Eliminate Route | 1.1 | % | 1.13 | % | Urinary excretion; | DRUGBANK |
Protein Binding | 99.0 | % | >99 | % | plasma proteins; human, homo sapiens; | DRUGBANK |
Property Name | Property Value | Unit | Raw Value | Raw Unit | Annotation | Brand Name | Component | Reference |
---|---|---|---|---|---|---|---|---|
Max dose for adults | 240.0 | mg/day | 240 | mg/day | PO, oral | Nerlynx | neratinib | PDR |
Max dose for geriatric | 240.0 | mg/day | 240 | mg/day | PO, oral | Nerlynx | neratinib | PDR |